We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

ECSC Ecsc Group Plc

0.00 (0.0%)
02 Oct 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Stock Type
Ecsc Group Plc ECSC London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.0% 52.50 01:00:00
Open Price Low Price High Price Close Price Previous Close
52.50 52.50
more quote information »
Industry Sector

Ecsc ECSC Dividends History

No dividends issued between 03 Oct 2013 and 03 Oct 2023

Top Dividend Posts

Top Posts
Posted at 26/6/2023 09:45 by maddox
rns 22 June 2023


Under the terms of the Scheme, Scheme Shareholders on the register of members of ECSC at the Scheme Record Time, being 6.00 p.m. on 21 June 2023, are entitled to receive 54.02 pence in cash for every Scheme Share held. Cheques will be dispatched to Scheme Shareholders holding Scheme Shares in certificated form and the CREST accounts of Scheme Shareholders holding Scheme Shares in uncertificated form will be credited within 14 days of today's date.'
Posted at 03/4/2023 09:03 by private38
Sad to see this go but the sector is painfully competitive with the likes of Arctic Wolf etc ripping through the market destroying any pricing power due to their massive marketing and sales budgets and "win the client at any cost attitude" these super niche players like ECSC have an increasingly tough row to hoe. Scale or sell are probably the only two options with the former being high risk. The consolidation of this sector is happening and I expect the likes of Falanx to follow. Darwinian.
Posted at 02/4/2023 22:56 by cerrito
At this stage, subject to the approval and availability of the Court (which is subject to change), Daisy and ECSC expect the Scheme to become Effective at the beginning of June 2023.
Posted at 01/2/2023 09:03 by gb904150
Not sure that's fair to call it sleight of hand. 3 wins of £690k is quite significant for a company with £3m mcap.

More significant is that they are in the MDR division. MDR wins are critical to the success of ECSC and I'd say the recent share price weakness has been due to the MDR pipeline being weak (was around £2.2m last set of results).

Covid hit the pipeline as that used to be a face to face selling function whereas now it's more hybrid.

In MDR they have high staff costs to cover - highly paid staff that have to cover X hours to. So that division has high operational leverage.

When it is low the GM's drop off sharply. When it is high it is much more efficient and with higher GM's.

From previous presentations the MDR wins are 3yr contracts, as they are here. There are some setup costs but then give us ARR's. Usually about 1/4 is billed upfront so they are immediately working capital positive.

In short, MDR is the profitable, scalable part of the business. The bigger it is the more efficient and higher GM's it is. So I'd say £690k wins there is pretty significant.

I'm not saying the forthcoming results will be fantastic, there will be a lag, but MDR is critical to ECSC's recovery and MDR contract wins suggest ECSC is recovering/improving/winning business.
Posted at 18/11/2022 18:04 by cerrito
Yes jane deer for that,
While it is easy for me to get to Mello.I did not join you as of all the companies presenting ECSC was the only one I follow.
Must have had some effect as by ECSC standards Tuesday and Wednesday with 21k and 25k shares traded were busy.
Posted at 29/10/2022 13:08 by melloteam
Just to let shareholders and prospective investors know that ECSC will be one of the companies presenting at MelloLondon, the two-day investor conference on Wednesday 16th and Thursday 17th November 2022. The event will also feature top quality keynote speakers such as Lord Lee, Katie Potts, Andy Brough, Gervais Williams and many more. You can also expect educational workshops and panel sessions; 50 exhibiting companies; and over 100 company presentations.

For more information, click here:

Tickets for 1 day are £99 and tickets for 2 days are £159. To get 50% off, use code MMTADVFN50.
Posted at 02/8/2022 12:21 by cerrito
I doubt if the new CEO will buy a significant amount of shares as one could argue he is taking some risk joining Ecsc although we will need to wait until the next AR to see his compensation.
He maybe in purdah until the interims come out.
Posted at 28/7/2022 12:25 by cerrito
I see the market has yawned at this morning’s news; perhaps like me they are trying to figure this out.
What it seems to me to be saying is that Mann is stronger on big vision as well as the techie stuff and not so good on the nuts and bolts of business leadership and hence the new recruit. Will be interesting to see him albeit virtually at the next IMC meeting. He does seem to have moved around quite a bit. I went to check if his previous company Auto protect is quoted so we could see why he left them but it is not. It certainly has a much bigger management team than ECSC and he must have left quite recently as the ceo is interim.
I would buy the argument that the current situation is not working well and such an appointment makes sense. One goes on the basis that there will be an expansion of business but there will be the two headwinds of a tight labour market and limited financial flexibility.
We need an extra NED sooner rather than later.
I went onto the Research Tree website to see if there was a note from Allenby with their comments on this but there was nothing.
Incidentally I saw the RNS of yesterday with the reduction in the holding of Ravindra Bahra which may account for some of the recent weakness.
Like I guess everyone on this Board I have a loss here. Not selling but will wait till the next IMC presentation before thinking of buying more.
Posted at 06/7/2022 10:32 by maddox
....but hopefully more to come.

With the mkt cap under £4m and valued at less than x1 historic sales ECSC are very lowly rated. The Managed Detection and Response (MDR) Division is high margin business and resource efficient - so these wins are in the sweet spot.

As can be seen from the wide client mix cyber security is a need across all sectors of the market and the trend is towards outsourcing detection monitoring. For the vast majority of firms having internal expensive dedicated resource for this activity 7 x 24 doesn't make sense. Also, the cyber threats are far easier to spot if you're monitoring across a range of firms rather than just one. So, this is the right proposition in a very large potential market.
Posted at 06/6/2022 23:32 by cerrito
I do not see myself making the AGM, especially if there are rail strikes.
I have gone through the AR.
My first reaction was its length 112 pages which seems OTT for such a small company and must be a barrier for small companies to list. I could not find on their websites their previous AR’s so no idea if they were bigger or smaller.
The following caught my eye
Page 12 I thought Lucy Sharp’s report read well.
Page 25 I saw the useful increase YOY in gross profit from the Assurance and decline in MDR but could find no good explanation of what drove these or indeed what business is in the assurance division and what in the ECR division.
Page 27 Be interesting to see if their EBITDA performance was good enough in H1 so they can increase their loan facility and begs the question as to why they need the funds.
Page 29 Note two risks have increased-economic conditions and hiring- the rest are no change and no risks have decreased.
Page 39 I see that the Chairman spends at least two working days a month on ECSC which I thought should be sufficient, even though he doubles up as Company Secretary. I see on page 42 that both he and Gooch attended all board meetings.
Page 43 A very stable shareholder base and indeed the last change of holdings RNS we had was way back in May 2020 after the latest equity issue. One concern I have had and continue to have is what would happen if either Unicorn or Ravinder Bahra wanted to exit. Fingers crossed that both remain if not happy at least satisfied and have no pressing need for cash. As an aside I have just been on the LSE website and seen since close of business on May 25 there have just been 4 transactions with a combined value of £12k in these 6 trading days…granted we did have the jubilee break but even so.
Page 46 I see that directors ‘remuneration as a whole fell from £829k to £731k, as one very highly paid director left, in the context that group expenses on employee benefits went up from £4.7m to £5.3m. The increase in expenditure at a group basis understandable given industry trends and no doubt there will be a big increase in 2022. This means that in 2021 directors’ remuneration was 14% of total-a bit high perhaps and certainly better than the 2020 figure of 18%. Note that as per page 87 total average number of employees was 87.
Given that in the IMC and other shareholder meetings Ian Mann gives the impression that ECSC is a one man band, I was pleasantly surprised that the differential between his and Lucy Sharp’s remuneration was as low as it was in 2021 and indeed in 2020 they had virtually identical remuneration.
Page 47 Let’s hope for all our sakes that the share options of the directors are in the money.
Page 80 Probably good that no single client accounts for more than 10% of the revenue.
Page 82 I note the reduction in contract liabilities. Given that it was inferred that the amount of 3 year contract work was increasing, this seems counter intuitive. Any views anyone
Page 86 Sobering but realistic that no deferred tax asset created quote because the Board envisages that a significant period of time will be required to generate sufficient profits to utilise the trading losses carried forward unquote…the trading losses being £5.4m
Page 89 Concerned that so few additions to the computer equipment. Anyone understand how the net book value of computer equipment has gone up from £68k to £658 k during 2021???
Page 97 Not only are the terms of the loan facility very onerous but we learn that there was a 1% fee payable.
Page 106 Interesting no share options were granted in 2021.
Not one of my better decisions to buy ECSC and well done to those who exited at the start of the year. I am suffering the consequences with the share price at current levels. Not sure what will provoke an uptick. Cannot see who would buy them. Any trading improvement will be a hard slog and the loan facility shows their lack of financial flexibility. I note that Allenby are currently forecasting a PBT loss this year 2022 of £308k up from last year’s loss of £277k. My last purchase was in July 2020.While not a Yorkshireman, I will show Yorkshire stubbornness and hang on with the marcap at £9m.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20231003 05:13:44